Search Results 2221-2230 of 22920 for Blood factor II

  1. Temozolomide and Irinotecan Hydrochloride with or without Bevacizumab in Treating Young Patients with Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors - Mayo Clinic

    About this study. This randomized phase II trial studies how well giving temozolomide and irinotecan hydrochloride together with or without bevacizumab ...

  2. Publications - Stefan K. Grebe, M.D., Ph.D. - Mayo Clinic

    ... 2 viral antigens from clinical samples. ... Factor-1. J Proteome Res. 2020 Jan 3; 19 (1):186 ... Blood. 2012 Sep 13; 120 (11):2280-9 Epub 2012 Aug ...

  3. Dinutuximab (intravenous route) - Side effects & uses - Mayo Clinic

    Description. Dinutuximab injection is used in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), ...

  4. Publications - Juan P. Brito Campana, M.B.B.S. - Mayo Clinic

    2024 Jun; 2 (2):270-279 Epub 2024 May 21. View ... conventional blood pressure goals in older ... Rates of, and factors associated with, switching ...

  5. Appendix cancer - Symptoms and causes - Mayo Clinic

    Epithelial appendix cancers include a few subtypes: Adenocarcinomas. These cancers start from the gland cells that line the appendix. There are two main types: ...

  6. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    This randomized phase II trial studies how well ... factor receptor (EGFR) mutations. Erlotinib may ... Bevacizumab blocks the ability of tumors to grow new blood ...

  7. Stress test - Mayo Clinic

    The coronary arteries are the major blood vessels that bring blood and oxygen to the heart. ... You'll soon start receiving the latest Mayo ... Low blood pressure.

  8. Coronary Bypass Surgery Clinical Trials - Mayo Clinic Research

    The researchers want to see whether opening the pericardium is an effective way to reduce the blood filling pressures in the heart. ... factors, early detection ...

  9. A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia with and without Red Blood Cell-Transfusion Dependence - Mayo Clinic

    A Phase 2, Multi-center, Open-label Study to ... Blood Cell-Transfusion Dependence. Print details ... This is a Phase 2, multicenter, open-label study ...

  10. Hypospadias - Symptoms and causes - Mayo Clinic

    This keeps the two sides of the urethral folds from joining completely. ... Risk factors. Although the cause of hypospadias is usually not known, these factors ...